Overexpression of α-2,6-sialyltransferase stimulates propagation of human influenza viruses in Vero cells

Acta Virologica

Volumn 55, Issue 2, 2011, Pages 147-153

  Li, N ^a   Qi, Y ^a   Zhang, F Y ^b   Yu, X H ^a   Wu, Y G ^a   Chen, Y ^a   Jiang, C L ^a   Kong, W ^a  

^a JILIN UNIVERSITY   (China)

^b Changchun BCHT biotechnology Co Ltd   (China)

Author keywords

2,6 sialyltransferase; Influenza virus; Vero cells

Indexed keywords

ALPHA 2,6 SIALYLTRANSFERASE; N ACETYL SIALIC ACID ALPHA 2,3 GALACTOSE; N ACETYL SIALIC ACID ALPHA 2,6 GALACTOSE; SIALIC ACID DERIVATIVE; SIALYLTRANSFERASE; UNCLASSIFIED DRUG; LEUKOCYTE ANTIGEN; ST6GAL1 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; INFLUENZA VIRUS; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; NONHUMAN; PROTEIN EXPRESSION; SIALYLATION; VERO CELL; VIRUS STRAIN; VIRUS TITRATION; ANIMAL; CERCOPITHECUS; EVALUATION; GENE EXPRESSION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; METHODOLOGY; PHYSIOLOGY; VIRUS CULTURE;

HUMAN INFLUENZA VIRUS; ORTHOMYXOVIRIDAE;

ANIMALS; ANTIGENS, CD; CERCOPITHECUS AETHIOPS; GENE EXPRESSION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; SIALYLTRANSFERASES; VERO CELLS; VIRUS CULTIVATION;

EID: 80052807596     PISSN: 0001723X     EISSN: None     Source Type: Journal    
DOI: 10.4149/av_2011_02_147     Document Type: Article

References (19)

1. Barrett PN, Mundt W, Kistner O, Howard MK (2009): Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines. Expert Rev. Vaccines 8, 607-618.
2. Belsey MJ, de Lima B, Pavlou AK, Savopoulos JW (2006): Influenza vaccines. Nat. Rev. Drug Discov. 5, 183-184.
3. Breen KC, Potratz A, Georgopoulou N, Sandhoff K (1998): The generation and characterization of a rat neural cell line overexpressing the alpha2,6(N) sialyltransferase. Glycoconj. J. 15, 199-202.
4. Connor RJ, Kawaoka Y, Webster RG, Paulson JC (1994): Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology 205, 17-23.
5. Couceiro JN, Paulson JC, Baum LG (1993): Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity. Virus Res. 29, 155-165.
6. Dall'Olio F, Chiricolo M, Lollini P, Lau JT (1995): Human colon cancer cell lines permanently expressing alpha 2,6-sialylated sugar chains by transfection with rat betagalactoside alpha 2,6 sialyltransferase cDNA. Biochem. Biophys. Res. Commun. 211, 554-561.
7. Fukuta K, Yokomatsu T, Abe R, Asanagi M, Makino T (2000): Genetic engineering of CHO cells producing human interferon-gamma by transfection of sialyltransferases. Glycoconj. J. 17, 895-904.
8. Gambaryan AS, Tuzikov AB, Piskarev VE, Yamnikova SS, Lvov DK, Robertson JS, Bovin NV, Matrosovich MN (1997): Specification of receptor-binding phenotypes of influenza virus isolates from different hosts using synthetic sialylglycopolymers: non-egg-adapted human H1 and H3 influenza A and influenza B viruses share a common high binding affinity for 6′-sialyl(N-acetyllactosamine). Virology 232, 345-350.
9. Govorkova EA, Kodihalli S, Alymova IV, Fanget B, Webster RG (1999): Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs. Dev. Biol. Stand. 98, 39-51.
10. Govorkova EA, Murti G, Meignier B, de Taisne C, Webster RG (1996): African green monkey kidney (Vero) cells provide an alternative host cell system for influenza A and B viruses. J. Virol. 70, 5519-5524.
11. Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB (2004): Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 53, 1-40.
12. Hatakeyama S, Sakai-Tagawa Y, Kiso M, Goto H, Kawakami C, Mitamura K, Sugaya N, Suzuki Y, Kawaoka Y (2005): Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor. J. Clin. Microbiol. 43, 4139-4146.
13. Katz JM, Wang M, Webster RG (1990): Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cellgrown virus. J. Virol. 64, 1808-1811.
14. Lin S, Kemmner W, Grigull S, Schlag PM (2002): Cell surface alpha 2,6 sialylation affects adhesion of breast carcinoma cells. Exp. Cell Res. 276, 101-110.
15. Matrosovich M, Matrosovich T, Carr J, Roberts NA, Klenk HD (2003): Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors. J. Virol. 77, 8418-8425.
16. Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD (2004). Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc. Natl. Acad. Sci. USA 101, 4620-4624.
17. Robertson JS, Bootman JS, Nicolson C, Major D, Robertson EW, Wood JM (1990): The hemagglutinin of influenza B virus present in clinical material is a single species identical to that of mammalian cell-grown virus. Virology 179, 35-40.
18. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, Fukuda K (2004): Influenza-associated hospitalizations in the United States. JAMA 292, 1333-1340.
19. Youil R, Su Q, Toner TJ, Szymkowiak C, Kwan WS, Rubin B, Petrukhin L, Kiseleva I, Shaw AR, DiStefano D (2004): Comparative study of influenza virus replication in Vero and MDCK cell lines. J. Virol. Methods 120, 23-31.